Sherman C. Smith

TL;DR: Long-term total mortality after gastric bypass surgery was significantly reduced, particularly deaths from diabetes, heart disease, and cancer, however, the rate of death from causes other than disease was higher in the surgery group than in the control group.

TL;DR: Among severely obese patients, compared with nonsurgical control patients, the use of RYGB surgery was associated with higher rates of diabetes remission and lower risk of cardiovascular and other health outcomes over 6 years.

TL;DR: Significant reduction in total cancer mortality in gastric bypass patients compared with severely obese controls was associated with decreased incidence, primarily among subjects with advanced cancers, supporting recommendations for reducing weight to lower cancer risk.

TL;DR: It is concluded that Roux‐en‐Y gastric bypass surgery when compared to severely obese groups not enrolled in planned weight‐loss intervention was highly effective for weight loss, improved health‐related quality of life, and resolution of major obesity‐associated complications measured at 2 years.

TL;DR: Retrograde intussusception of the jejunum after gastric bypass is probably more common than previously believed and resection and revision of the area of intussedusception appears to be effective.